A New Pyrimidine-Specific Reporter Gene: A Mutated Human Deoxycytidine Kinase Suitable for PET During Treatment with Acycloguanosine-Based Cytotoxic Drugs

In this article, we describe a series of new human-derived reporter genes based on human deoxycytidine kinase (dCK) suitable for clinical PET. Methods: Native dCK and its mutant reporter genes were tested in vitro and in vivo for their phosphorylation of pyrimidine- and acycloguanosine-based radiotracers including 2′-deoxy-2′-fluoroarabinofuranosylcytosine, 2′-fluoro-2′-deoxyarabinofuranosyl-5-ethyluracil (FEAU), penciclovir, and 9-[4-fluoro-3-(hydroxymethyl)butyl]guanine (FHBG) and clinically applied antiviral and anticancer drugs. Results: Cells transduced with dCK mutant reporter genes showed high in vitro and in vivo uptake of pyrimidine-based radiopharmaceuticals (18F-FEAU) comparable to that of herpes simplex virus type-1 thymidine kinase (HSV1-tk)–transduced cells. These mutants did not phosphorylate acycloguanosine-based radiotracers (18F-FHBG) or antiviral drugs (ganciclovir). Furthermore, the mutants displayed suicidal activation of clinically used pyrimidine-based prodrugs (cytarabine, gemcitabine). Conclusion: The mutants of human dCK can be used as pyrimidine-specific PET reporter genes for imaging with 18F-FEAU during treatment with acycloguanosine-based antiviral drugs. Additionally, the prosuicidal activity of these reporters with pyrimidine-based analogs will allow for the safe elimination of transduced cells.

[1]  H. Hricak,et al.  PET imaging of HSV1-tk mutants with acquired specificity toward pyrimidine- and acycloguanosine-based radiotracers , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  M. Konrad,et al.  Extending thymidine kinase activity to the catalytic repertoire of human deoxycytidine kinase. , 2009, Biochemistry.

[3]  Michel Sadelain,et al.  Monitoring the Efficacy of Adoptively Transferred Prostate Cancer–Targeted Human T Lymphocytes with PET and Bioluminescence Imaging , 2008, Journal of Nuclear Medicine.

[4]  Michael E. Phelps,et al.  Molecular imaging of lymphoid organs and immune activation using positron emission tomography with a new 18F-labeled 2′-deoxycytidine analog , 2008, Nature Medicine.

[5]  S. Lutz,et al.  Systematic exploration of active site mutations on human deoxycytidine kinase substrate specificity. , 2008, Biochemistry.

[6]  M. Konrad,et al.  Mimicking phosphorylation of Ser‐74 on human deoxycytidine kinase selectively increases catalytic activity for dC and dC analogues , 2008, FEBS letters.

[7]  M. Sadelain,et al.  T cell–encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection , 2007, Nature Medicine.

[8]  C. Bordignon,et al.  The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies. , 2007, Blood.

[9]  R. Blasberg,et al.  Imaging hNET Reporter Gene Expression with 124I-MIBG , 2007, Journal of Nuclear Medicine.

[10]  V. Ponomarev,et al.  A Human-Derived Reporter Gene for Noninvasive Imaging in Humans: Mitochondrial Thymidine Kinase Type 2 , 2007, Journal of Nuclear Medicine.

[11]  D. Brennan,et al.  Prevention and management of cytomegalovirus infection in solid-organ transplantation , 2007, Expert review of anti-infective therapy.

[12]  E. Warren,et al.  Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation. , 2006, Blood.

[13]  Michel Sadelain,et al.  Targeted elimination of prostate cancer by genetically directed human T lymphocytes. , 2005, Cancer research.

[14]  J. Wolchok,et al.  Induction of autoantibodies to syngeneic prostate‐specific membrane antigen by xenogeneic vaccination , 2005, International journal of cancer.

[15]  E. Ahrens,et al.  A new transgene reporter for in vivo magnetic resonance imaging , 2005, Nature Medicine.

[16]  R. Blasberg,et al.  hNIS-IRES-eGFP Dual Reporter Gene Imaging , 2005, Molecular imaging.

[17]  J. Barrio,et al.  Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography , 2005, Cancer Gene Therapy.

[18]  Vladimir Ponomarev,et al.  Molecular Imaging of Temporal Dynamics and Spatial Heterogeneity of Hypoxia-Inducible Factor-1 Signal Transduction Activity in Tumors in Living Mice , 2004, Cancer Research.

[19]  P. Cornea,et al.  Review of antiviral therapy for herpes labialis, genital herpes and herpes zoster , 2003, Expert review of anti-infective therapy.

[20]  C. Monnerjahn,et al.  Structure of human dCK suggests strategies to improve anticancer and antiviral therapy , 2003, Nature Structural Biology.

[21]  R. Blasberg,et al.  Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of noninvasive molecular-genetic imaging. , 2003, Neoplasia.

[22]  Michel Sadelain,et al.  Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes , 2003, Nature Biotechnology.

[23]  Sanjiv S Gambhir,et al.  Quantitative imaging of the T cell antitumor response by positron-emission tomography , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Weissleder,et al.  Human transferrin receptor gene as a marker gene for MR imaging. , 2001, Radiology.

[25]  J Humm,et al.  Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  N. Bander,et al.  Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen. , 1999, Neoplasia.

[27]  S. Cherry,et al.  Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals , 1999, Gene Therapy.

[28]  P. Conti,et al.  Synthesis and preliminary evaluation of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG): a new potential imaging agent for viral infection and gene therapy using PET. , 1998, Nuclear medicine and biology.

[29]  A. Karlsson,et al.  Human deoxycytidine kinase is located in the cell nucleus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. van Kaick,et al.  Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  T. Reynolds,et al.  T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients , 1996, Nature Medicine.

[32]  R. Blasberg,et al.  Imaging the expression of transfected genes in vivo. , 1995, Cancer research.

[33]  L. Kvols,et al.  Distribution of somatostatin receptors in normal and tumor tissue. , 1990, Metabolism: clinical and experimental.

[34]  D. Paik,et al.  Noninvasive detection of therapeutic cytolytic T cells with 18F–FHBG PET in a patient with glioma , 2009, Nature Clinical Practice Oncology.

[35]  S. Gambhir,et al.  Molecular imaging of PET reporter gene expression. , 2008, Handbook of experimental pharmacology.

[36]  Sanjiv S Gambhir,et al.  Indirect monitoring of endogenous gene expression by positron emission tomography (PET) imaging of reporter gene expression in transgenic mice. , 2002, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[37]  S. Larson,et al.  Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo. , 2001, Neoplasia.

[38]  M. Sadelain,et al.  Methods for the construction of retroviral vectors and the generation of high-titer producers. , 1997, Methods in molecular medicine.

[39]  Elias S. J. Arnér,et al.  Mammalian deoxyribonucleoside kinases. , 1995, Pharmacology & therapeutics.